Biosite Inc. Recalls Cardiac Marker Test

Law360, New York (May 6, 2009, 12:00 AM EDT) -- Research-based diagnostics company Biosite Inc. has issued a nationwide recall of one lot of its Triage Cardiac Panel, a product used to diagnose heart attacks, because of a defect that could possibly lead to a wrong diagnosis.

On Tuesday, the company voluntarily recalled 401 of its Triage Cardiac Panel kits because of “reports of low recovery of quality control samples containing Creatine Kinase MB (CK-MB), troponin I and myoglobin on the affected lot."

“Although there have been no reported issues of patient misdiagnosis associated with this...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.